Top MarketRank™ StocksTop MarketRank™NYSE:CHE Chemed (CHE) Stock Price, News & Analysis $561.15 -13.59 (-2.36%) Closing price 03:59 PM EasternExtended Trading$560.75 -0.40 (-0.07%) As of 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Chemed Stock (NYSE:CHE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Chemed alerts:Sign Up Key Stats Today's Range$549.21▼$577.3050-Day Range$517.44▼$574.2652-Week Range$512.12▼$654.62Volume170,510 shsAverage Volume98,275 shsMarket Capitalization$8.45 billionP/E Ratio28.36Dividend Yield0.36%Price Target$641.50Consensus RatingBuy Company OverviewChemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Read More… Chemed Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks99th Percentile Overall ScoreCHE MarketRank™: Chemed scored higher than 99% of companies evaluated by MarketBeat, and ranked 17th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingChemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageChemed has only been the subject of 1 research reports in the past 90 days.Read more about Chemed's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.73% Earnings GrowthEarnings for Chemed are expected to grow by 8.73% in the coming year, from $21.43 to $23.30 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemed is 28.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.07.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemed is 28.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.73.Price to Earnings Growth RatioChemed has a PEG Ratio of 2.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemed has a P/B Ratio of 7.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Chemed's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.88% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Chemed has recently increased by 3.88%, indicating that investor sentiment is decreasing. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldChemed has a dividend yield of 0.36%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthChemed has been increasing its dividend for 16 years.Dividend CoverageThe dividend payout ratio of Chemed is 10.11%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemed will have a dividend payout ratio of 8.58% next year. This indicates that Chemed will be able to sustain or increase its dividend.Read more about Chemed's dividend. Sustainability and ESG4.9 / 5Environmental Score-0.33 Percentage of Shares Shorted1.88% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Chemed has recently increased by 3.88%, indicating that investor sentiment is decreasing. News and Social Media3.6 / 5News Sentiment1.45 News SentimentChemed has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Chemed this week, compared to 6 articles on an average week.Search Interest5 people have searched for CHE on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat Follows2 people have added Chemed to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Chemed insiders have sold 1,980.10% more of their company's stock than they have bought. Specifically, they have bought $75,328.00 in company stock and sold $1,566,894.00 in company stock.Percentage Held by InsidersOnly 3.32% of the stock of Chemed is held by insiders.Percentage Held by Institutions95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Chemed's insider trading history. Receive CHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. Email Address CHE Stock News HeadlinesChemed Co. (NYSE:CHE) VP Brian C. Judkins Purchases 145 SharesDecember 31, 2024 | insidertrades.comHere's How Much $1000 Invested In Chemed 20 Years Ago Would Be Worth TodayJanuary 21, 2025 | benzinga.comMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration.January 28, 2025 | InvestorPlace (Ad)Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare ConferenceJanuary 7, 2025 | businesswire.comInsider Buying: Brian Judkins Acquires Shares of Chemed Corp (CHE)December 30, 2024 | gurufocus.comIs There An Opportunity With Chemed Corporation's (NYSE:CHE) 31% Undervaluation?December 26, 2024 | finance.yahoo.com$100 Invested In Chemed 10 Years Ago Would Be Worth This Much TodayDecember 16, 2024 | benzinga.comChemed Corporation to Present at the BofA Securities 2024 Virtual Home Care ConferenceDecember 3, 2024 | businesswire.comSee More Headlines CHE Stock Analysis - Frequently Asked Questions How have CHE shares performed this year? Chemed's stock was trading at $529.80 at the start of the year. Since then, CHE stock has increased by 6.0% and is now trading at $561.3270. View the best growth stocks for 2025 here. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) released its quarterly earnings results on Tuesday, October, 29th. The company reported $5.64 EPS for the quarter, missing analysts' consensus estimates of $5.76 by $0.12. The firm's revenue for the quarter was up 7.4% on a year-over-year basis. Who are Chemed's major shareholders? Chemed's top institutional shareholders include Boston Trust Walden Corp (1.61%), Copeland Capital Management LLC (1.01%), Riverbridge Partners LLC (0.52%) and Retirement Systems of Alabama (0.28%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Nicholas Michael Westfall, Andrea R Lindell, Donald E Saunders, Patrick P Grace, George J Walsh III, Michael D Witzeman and Brian C Judkins. View institutional ownership trends. How do I buy shares of Chemed? Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Chemed own? Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY). Company Calendar Last Earnings10/29/2024Ex-Dividend for 12/6 Dividend11/18/2024Dividend Payable12/06/2024Today1/28/2025Next Earnings (Estimated)2/25/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Home health care services Sub-IndustryHealth Care Services Current SymbolNYSE:CHE CUSIP16359R10 CIK19584 Webwww.chemed.com Phone(513) 762-6690Fax513-762-6590Employees15,087Year Founded1970Price Target and Rating Average Stock Price Target$641.50 High Stock Price Target$650.00 Low Stock Price Target$633.00 Potential Upside/Downside+14.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$19.79 Trailing P/E Ratio28.36 Forward P/E Ratio26.19 P/E Growth2.15Net Income$272.51 million Net Margins12.69% Pretax Margin16.61% Return on Equity27.86% Return on Assets19.12% Debt Debt-to-Equity RatioN/A Current Ratio1.85 Quick Ratio1.81 Sales & Book Value Annual Sales$2.26 billion Price / Sales3.73 Cash Flow$25.01 per share Price / Cash Flow22.44 Book Value$73.55 per share Price / Book7.63Miscellaneous Outstanding Shares15,050,000Free Float14,550,000Market Cap$8.45 billion OptionableOptionable Beta0.47 Social Links 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:CHE) was last updated on 1/28/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.